newsfilter
← Latest News
Business Wire·

Paul J. Diaz Elected to Merck & Co., Inc., Rahway, N.J., USA Board of Directors

  • Merck & Co., Inc. announced Paul J. Diaz will join its Board of Directors effective November 1, 2026.
  • Diaz will stand for election by shareholders in May 2027.
  • The addition of Diaz increases the Merck board membership to 14 members.
  • Diaz currently serves as managing partner at Cressey & Company, a private investment firm focused on healthcare.
  • Diaz previously served as CEO of Myriad Genetics, Inc. & Kindred Healthcare.
  • Diaz holds board seats at Centene Corporation, Johns Hopkins Medicine, & Georgetown University Law Center.
  • Diaz earned a bachelor's degree in finance & accounting from American University & a J.D. from Georgetown University.
  • Rob Davis, Merck chairman & CEO, welcomed Diaz for his extensive healthcare leadership expertise.
  • The news release includes standard forward-looking statements regarding risks such as regulation, competition, & product development.